q12

Documents about q12

• Do Zambian Farmers Manage Climate Risks?#371044Kyoto University Research Information Repository
• Do Zambian Farmers Manage Climate Risks?#371097Kyoto University Research Information Repository
• Does Organic Farming Jeopardize Food and Nutrition Security?#17267EconStor
• The impact of commercialization of rice on household welfare in rural Viet Nam#17179EconStor
• Gendered effects of climate and conflict shocks on food security in Sudan and the mitigating role of social protection#16805EconStor
• Farm Size Distribution, Weather Shocks, and Agricultural Productivity#345653Repositorio institucional Séneca
• Adoption and ex-post impact of agricultural technologies on rural poverty: Evidence from Amhara Region, Ethiopia#17020EconStor
• Women’s empowerment for farm resilience in Ethiopia: A three-step approach for latent class analysis#191647EconStor
• Gendered effects of climate and conflict shocks on food security in Sudan and the mitigating role of social protection#641928EconStor
• Farmers' participation in messenger‐based social groups and its effects on performance in irrigated areas of Kazakhstan and Uzbekistan#405472EconStor
• The Impact of Access to Credit on the Adoption of hybrid maize in Malawi: An Empirical test of an Agricultural Household Model under credit market failure#499506Munich Personal RePEc Archive
• Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia#873797ClinicalTrials.gov
• Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia#967840ClinicalTrials.gov
• La modernización agrícola en México: Una estocada sobre la economía campesina#302415RU-Económicas
• Del consumo de alimentos en América Latina#455923RU-Económicas
• Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia#841751ClinicalTrials.gov
• Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia#917363ClinicalTrials.gov
• Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission#407778ClinicalTrials.gov
• Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia#290983ClinicalTrials.gov
• Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant#201796ClinicalTrials.gov
• The Limits to Common Resource Management: The Bypassed Commons or Commons without Tragedy#499813Munich Personal RePEc Archive
• G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders#835719ClinicalTrials.gov
• Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia#886251ClinicalTrials.gov
• Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia#992957ClinicalTrials.gov
• Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia#884716ClinicalTrials.gov
• Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia#898835ClinicalTrials.gov
• Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation#467591ClinicalTrials.gov
• Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer#851052ClinicalTrials.gov
• Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia#834181ClinicalTrials.gov
• Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer#917902ClinicalTrials.gov
• Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant#876217ClinicalTrials.gov
• Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes#849188ClinicalTrials.gov
• S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin#893399ClinicalTrials.gov
• Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil#872291ClinicalTrials.gov
• Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer#908606ClinicalTrials.gov
• Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720#891740ClinicalTrials.gov
• Sunitinib in Treating Patients With Idiopathic Myelofibrosis#885647ClinicalTrials.gov
• Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant#802893ClinicalTrials.gov
• Healing Touch in Treating Patients Receiving Chemotherapy for Acute Myeloid Leukemia or Acute Lymphocytic Leukemia#829693ClinicalTrials.gov
• Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases#813531ClinicalTrials.gov
• Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders#906637ClinicalTrials.gov
• Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML#875244ClinicalTrials.gov
• Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies#837867ClinicalTrials.gov
• Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders#895794ClinicalTrials.gov
• Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer#805930ClinicalTrials.gov
• Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant#856189ClinicalTrials.gov
• Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment#805034ClinicalTrials.gov
• Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes#854569ClinicalTrials.gov
• Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer#907609ClinicalTrials.gov
• S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia#980136ClinicalTrials.gov